Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274480 · ClinicalTrials.gov registry record
Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 28
- Enrollment target
NCT02274480: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02274480 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02274480 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The goal of this study is to see if a special type of heart scan called a diffusion weighted magnetic resonance imaging (DW-MRI) that uses extra measurements, can be used to find early signs of heart damage from chemotherapy.
Interventions
- DEVICE cardiac MRI with DWI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-10-22 |
| Est. Completion | 2020-09-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02274480
The ClinicalTrials.gov registry entry for NCT02274480 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cardiac MRI with DWI is the first listed.
NCT02274480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02274480 about?
NCT02274480 is a clinical study titled "Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity". The goal of this study is to see if a special type of heart scan called a diffusion weighted magnetic resonance imaging (DW-MRI) that uses extra measurements, can be used to find early signs of heart damage from chemotherapy.
What is the current status of trial NCT02274480?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2014-10-22. Estimated completion is 2020-09-02.
What interventions are being tested in trial NCT02274480?
The interventions under investigation include: cardiac MRI with DWI (DEVICE).
Who is sponsoring clinical trial NCT02274480?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.